Here, Cardinal Health CEO Jason Holler joins us live. Sir, thank you for being here in a Fox Business exclusive. You distribute drugs to what 90% of US hospitals, 29,000ies worldwide.That's a lot of patients who depend on you. How closely are you watching this battle over the extension of the Obamacare subsidies. >> Uh, yeah, of course.It's it's something that we look at every single day as well as the broader policy potential changes that are out there. And and I I think at the highest levels, what's what' ...

公司股价表现 - 公司股价在周四大幅上涨超过15% [1] - 公司股价表现远超基准标普500指数 后者当日下跌1% [1] 财务业绩表现 - 2026财年第一季度收入同比增长22%至640亿美元 [2] - 非GAAP净利润同比飙升37%至8.57亿美元 折合每股收益2.55美元 [2] - 当季所有五个运营部门均实现增长 [3] - 其中最大的制药和专业解决方案部门收入同比增长23%至超过590亿美元 [3] 业绩与预期对比 - 公司实际收入远超分析师普遍预期的略高于590亿美元 [3] - 公司实际非GAAP每股收益远超分析师普遍预期的2.19美元 [3] 业绩指引更新 - 公司连续第二次上调2026财年全年业绩指引 [4] - 预计调整后每股收益为9.65美元至9.85美元 预期同比增长至少17% 此前指引为9.30美元至9.50美元 [4] - 预计调整后自由现金流为30亿美元至35亿美元 此前指引为27.5亿美元至32.5亿美元 [4]